Magnasense AB (STO:MAGNA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0134
-0.0006 (-4.29%)
At close: Jun 5, 2025
-97.77%
Market Cap 15.89M
Revenue (ttm) n/a
Net Income (ttm) -49.63M
Shares Out 1.19B
EPS (ttm) -1.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,742,580
Average Volume 9,199,484
Open 0.0144
Previous Close 0.0140
Day's Range 0.0125 - 0.0144
52-Week Range 0.0125 - 0.7200
Beta 2.37
RSI 18.65
Earnings Date May 16, 2025

About Magnasense AB

Magnasense AB develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs in Sweden and internationally. The company develops a home testing platform for oral health, therapeutic drug monitoring, and infectious diseases. Its product line includes the Veritope technology with intact natalizumab in multiple sclerosis; and the MagniaReader which is utilized in research and veterinary applications. The company was formerly known as AegirBio AB (publ) and changed its name to Magnasense AB in July 2024. M... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2019
Employees 14
Stock Exchange Nasdaq Stockholm
Ticker Symbol MAGNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.